Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent s-1-based neoadjuvant/adjuvant chemotherapy.]

[Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent s-1-based neoadjuvant/adjuvant chemotherapy.] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent s-1-based neoadjuvant/adjuvant chemotherapy.] Abstract Text:

    S-1, a most effective DPD-inhibitory fluoropyrimidine, used as neoadjuvant/adjuvant chemotherapy has recently been shown to improve clinical outcome in patients with stage II and III advanced stage gastric carcinoma. Orotate phosphoribosyltransferase(OPRTEC 2.4.2.10)is a primary enzyme involved in the first-step phosphorylation process of 5-fluorouracil and is an important enzyme that possibly enables to predict sensitivity to S-1 irrespective of tissue DPD levels. To test the hypothesis that a low OPRT level in gastric carcinoma tissue is an indicator of chemoresistance to S-1-based chemotherapy, the predictive value of OPRT levels in chemoresistance was evaluated in patients with gastric carcinoma undergoing S-1-based-neoadjuvant/adjuvant chemotherapy using survival analyses. A total of 67 patients with advanced-stage gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy were subjected to the study. The OPRT level was determined by an enzyme-linked immunosorbent assay(ELISA)that has recently been developed. Postoperative cumulative survival rates were determined by the Kaplan-Meier method. The patients who underwent S-1-based adjuvant/neoadjuvant chemotherapy(n=67)were divided into 2 groups using various cut-off values to determine the prognostic significance of the OPRT level. The prognostic significance of OPRT levels was analyzed using Cox's proportional hazard model. The P value of the survival rate between the groups of low and high OPRT levels was the lowest(p=0.0018), when 2.0 ng/mg protein was used as a cut-off value for the OPRT level. The 3-year survival rate of Group L and Group H was 0% and 60%, respectively. In particular, there was a significant difference in the survival rates between Group L and Group H in stage III patients(p<0.05 by logrank test). T he survival rate of Group L(OPRT<2.0 ng/mg protein)was significantly lower than that of group H(OPRT>/=2.0 ng/mg protein)(p<0.05 by logrank test). The multivariate analysis using Cox' proportional hazard model indicated that venous invasion of carcinoma(>v2), lymph node metastasis(>5), and low OPRT level (OPRT<2.0 ng/mg protein) were significant prognostic factors in patients who were underwent S-1-based neoadjuvant/adjuvant chemotherapy. These results suggest that patients with a low OPRT level(OPRT<2.0 ng/mg protein)are non-responders to S-1- based adjuvant/neoadjuvant chemotherapy. The determination of OPRT levels in gastric carcinoma tissue enables to predict the response to S-1-based neoadjuvant/adjuvant chemotherapy.

    [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent s-1-based neoadjuvant/adjuvant chemotherapy.] Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent s-1-based neoadjuvant/adjuvant chemotherapy.] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Gan to kagaku ryoho. Cancer & chemotherapy

    VOLUME: 35

    Page Numbers: 1147-55

    Journal Abbreviation: Gan To Kagaku Ryoho

    ISSN: 0385-0684

    DAY: 17

    MONTH: Jul

    YEAR: 2008

    [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent s-1-based neoadjuvant/adjuvant chemotherapy.] Information

    Number of References:

    LANGUAGE: jpn

    NlmUniqueID: 7810034

    [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent s-1-based neoadjuvant/adjuvant chemotherapy.] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent s-1-based neoadjuvant/adjuvant chemotherapy.] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent s-1-based neoadjuvant/adjuvant chemotherapy.]

    AFFILIATION: Dept. of Surgery, Fujita Health University School of Medicine.

    Country: Japan

    Japan Research PublicationJapan Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Gan To Kagaku Ryoho

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent s-1-based neoadjuvant/adjuvant chemotherapy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News